For most of the last decade, the word clean did the heavy lifting in beauty marketing. It signalled a specific ingredient philosophy, an implicit critique of the incumbents, and — increasingly — a price permission. A serum could charge fifty dollars if the front of the pack said clean. A body wash could double its unit economics with a Free From list. Clean was a differentiator, and it worked.
In 2026, that era is finished. Not because consumers stopped caring — they care more than ever — but because clean has become table stakes. Every prestige retailer now enforces a version of it. Every marketplace has its own restricted-ingredient list. Every serious contract manufacturer has a clean-capable line. If your positioning still hinges on being the clean one, you don't have a positioning.
What replaced it
Three claims have quietly taken clean's job. None of them are new. All of them are much harder to fake.
Efficacy. The most valuable claim in prestige skincare in 2026 is this works, evidenced by a clinical trial the founder actually ran. Fifty consumers, four weeks, one measurable endpoint, third-party dermatologist review. A short, boring PDF the buyer can put in her file. It costs $30–80k, and it is the single best money most emerging brands can spend.
Sourcing story. Where an ingredient comes from — the farm, the cooperative, the country, the ethics — has become the second-highest-value claim after efficacy. Not we source responsibly in a paragraph nobody reads, but a specific origin, a specific person, a specific reason it matters. This is expensive to build and impossible to fake. Which is exactly why it works.
Price transparency. A slow-growing but powerful third claim. Brands that publish their cost structure — not their entire P&L, but a directional breakdown of what a $48 serum is made of — earn a kind of trust that no amount of clean signalling ever bought. It's the beauty version of open-book restaurants. Consumers reward it.
If your positioning still hinges on being the clean one, you don't have a positioning.
What this changes for founders
If you're building a brand in 2026, three things follow.
Treat clean as a supplier requirement, not a marketing claim. Write your Restricted Substances List, hand it to your manufacturer, verify with a third party, and never say the word again on the front of the pack. Save the space for what matters.
Budget for a trial. If your product has any efficacy claim at all — hydration, firmness, sebum control, hair strength, comfort — trial it. Even a modest study will change how buyers, journalists, and consumers relate to your brand. Untrialled efficacy claims are increasingly a legal risk in the US and a listing risk in the EU.
Pick a claim you can defend for five years. A hero claim is a commitment, not a campaign. Once you build a brand around scalp-microbiome science or Amazon-sourced butters, you cannot pivot without confusing the consumer. Choose deliberately.
What this changes for retailers
The buyers we speak to have grown quietly bored of clean-only pitches. What they want, in order: a category-defining product, evidence, and a marketing plan that doesn't rely on the retailer's own store credit line. A clean claim used to make it into the top three. It no longer does.
This is not because retailers are cynical. It's because their consumer expects clean by default now. If a listed brand isn't clean, that's a listing error, not a positioning coup by the ones that are.
The upside
The end of clean-as-differentiator is, on balance, very good news for the founders we work with. The playing field is flatter. The tests are more objective. What wins is more likely to be the best product, not the best copywriting.
That's the world we've always wanted to build in. In 2026, it's finally here.